Modification and uptake of a cisplatin carbonato complex by Jurkat cells

被引:38
作者
Centerwall, Corey R.
Tacka, Kirk A.
Kerwood, Deborah J.
Goodisman, Jerry
Toms, Bonnie B.
Dubowy, Ronald L.
Dabrowiak, James C.
机构
[1] Syracuse Univ, Dept Chem, Syracuse, NY 13244 USA
[2] SUNY Upstate Med Univ, Dept Pediat, Syracuse, NY USA
关键词
D O I
10.1124/mol.106.023184
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
The interactions of Jurkat cells with cisplatin, cis-[Pt((NH3)-N-15)(2)Cl-2](1), are studied using H-1-N-15 heteronuclear single quantum coherence (HSQC) NMR and inductively coupled plasma mass spectrometry. We show that Jurkat cells in culture rapidly modify the monocarbonato complex cis-[Pt((NH3)-N-15)(2)(CO3)Cl](-) (4), a cisplatin species that forms in culture media and probably also in blood. Analysis of the HSQC NMR peak intensity for 4 in the presence of different numbers of Jurkat cells reveals that each cell is capable of modifying 0.0028 pmol of 4 within similar to 0.6 h. The amounts of platinum taken up by the cell, weakly bound to the cell surface, remaining in the culture medium, and bound to genomic DNA were measured as functions of time of exposure to different concentrations of drug. The results show that most of the 4 that has been modified by the cells remains in the culture medium as a substance of molecular mass < 3 kDa, which is HSQC NMR silent, and is not taken up by the cell. These results are consistent with a hitherto undocumented extracellular detoxification mechanism in which the cells rapidly modify 4, which is present in the culture medium, so it cannot bind to the cell. Because there is only a slow decrease in the amount of unmodified 4 remaining in the culture medium after 1 h, -1.1 +/- 0.4 mu M h(-1), the cells subsequently lose their ability to modify 4. These observations have important implications for the mechanism of action of cisplatin.
引用
收藏
页码:348 / 355
页数:8
相关论文
共 26 条
[1]
Carbonato complexes: Models for carbonic anhydrase [J].
Acharya, AN ;
Das, A ;
Dash, AC .
ADVANCES IN INORGANIC CHEMISTRY: INCLUDING BIOINORGANIC STUDIES, VOL 55, 2004, 55 :127-199
[2]
USE OF A TRYPAN BLUE ASSAY TO MEASURE THE DEOXYRIBONUCLEIC-ACID CONTENT AND RADIOACTIVE LABELING OF VIABLE CELLS [J].
ALLISON, DC ;
RIDOLPHO, P .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1980, 28 (07) :700-703
[3]
Berners-Price SJ, 2000, CANC DRUG DISC DEV, V7, P3
[4]
Formation of monofunctional cisplatin-DNA adducts in carbonate buffer [J].
Binter, Alexandra ;
Goodisman, Jerry ;
Dabrowiak, James C. .
JOURNAL OF INORGANIC BIOCHEMISTRY, 2006, 100 (07) :1219-1224
[5]
Boulikas T, 2004, ONCOL REP, V11, P559
[6]
Modifications of DNA by platinum complexes - Relation to resistance of tumors to platinum antitumor drugs [J].
Brabec, V ;
Kasparkova, J .
DRUG RESISTANCE UPDATES, 2005, 8 (03) :131-146
[7]
Cisplatin carbonato complexes. Implications for uptake, antitumor properties, and toxicity [J].
Centerwall, CR ;
Goodisman, J ;
Kerwood, DJ ;
Dabrowiak, JC .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (37) :12768-12769
[8]
Activation of carboplatin by carbonate [J].
Di Pasqua, AJ ;
Goodisman, J ;
Kerwood, DJ ;
Toms, BB ;
Dubowy, RL ;
Dabrowiak, JC .
CHEMICAL RESEARCH IN TOXICOLOGY, 2006, 19 (01) :139-149
[9]
Eastman A., 1999, CISPLATIN CHEM BIOCH, P111, DOI DOI 10.1002/9783906390420.CH4
[10]
Reactions of cisplatin hydrolytes with methionine, cysteine, and plasma ultrafiltrate studied by a combination of HPLC and NMR techniques [J].
El-Khateeb, M ;
Appleton, TG ;
Gahan, LR ;
Charles, BG ;
Berners-Price, SJ ;
Bolton, AM .
JOURNAL OF INORGANIC BIOCHEMISTRY, 1999, 77 (1-2) :13-21